Literature DB >> 7026614

Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium.

G J Anhalt, C F Bahn, R S Labib, J J Voorhees, A Sugar, L A Diaz.   

Abstract

Bullous pemphigoid (BP) is associated with circulating autoantibodies reactive with an antigen(s) of the basement membrane zone (BMZ) of skin and mucosae. The pathogenicity of these autoantibodies, although suspected, is unconfirmed. We have investigated the effects of BP autoantibodies on a closely related tissue, the corneal epithelium of the rabbit. IgG fractions from the sera of seven patients with BP were purified by (a) ammonium sulfate precipitation, (b) ion exchange chromatography, or (c) gel filtration. Control IgG was prepared by ion exchange chromatography of pooled normal human gamma globulins. 32 rabbits received corneal intrastromal injections of BP IgG fractions (50 microliter, 0.95-2.05 mg total dose) in one eye, and control IgG (50 microliter, 1.8 mg) in the contralateral cornea. 28 of 32 BP IgG injections produced corneal inflammatory lesions, 10 of which developed visible blisters. Histologically, lesions showed polymorphonuclear cells clustering along the BMZ, and subepithelial blister formation. Immunofluorescence showed in vivo bound IgG and C3 at the BMZ. The intensity of inflammation was dose dependent and correlated often with in vitro complement fixation titers of the fractions. None of 32 corneas injected with control IgG became inflamed. BP IgG fractions injected intradermally into the ear skin of rabbits failed to produce inflammation. This may be due to slow clearance of IgG in the cornea, and optimal binding by the corneal epithelium. The intracorneal injections of BP IgG reproduce the clinical, histological, and immunological features of BP. This study provides evidence that BP autoantibodies are pathogenic.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026614      PMCID: PMC370898          DOI: 10.1172/jci110333

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  9 in total

1.  A spectrophotometric determination of trypsin and chymotrypsin.

Authors:  G W SCHWERT; Y TAKENAKA
Journal:  Biochim Biophys Acta       Date:  1955-04

Review 2.  Ocular surface manifestations of neurological and systemic disease.

Authors:  C S Foster
Journal:  Int Ophthalmol Clin       Date:  1979

Review 3.  Immunologically privileged sites.

Authors:  C F Barker; R E Billingham
Journal:  Adv Immunol       Date:  1977       Impact factor: 3.543

4.  Basement zone antibodies in bullous pemphigoid.

Authors:  R E Jordon; E H Beutner; E Witebsky; G Blumental; W L Hale; W F Lever
Journal:  JAMA       Date:  1967-05-29       Impact factor: 56.272

5.  Complement activation in pemphigus and bullous pemphigoid.

Authors:  R E Jordon
Journal:  J Invest Dermatol       Date:  1976-09       Impact factor: 8.551

6.  Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.

Authors:  W R Gammon; D M Lewis; J R Carlo; W M Sams; C E Wheeler
Journal:  J Invest Dermatol       Date:  1980-10       Impact factor: 8.551

7.  Proteins in aqueous humor.

Authors:  M Zirm
Journal:  Adv Ophthalmol       Date:  1980

8.  The dynamics of IgG in the cornea.

Authors:  M Allansmith; A de Ramus; D Maurice
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-09       Impact factor: 4.799

9.  Failure to transfer bullous pemphigoid with serum from patients.

Authors:  W M Sams; G J Gleich
Journal:  Proc Soc Exp Biol Med       Date:  1971-04
  9 in total
  11 in total

Review 1.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

2.  Cicatricial pemphigoid.

Authors:  C S Foster
Journal:  Trans Am Ophthalmol Soc       Date:  1986

3.  Induction of autoantibodies to rat corneal protein 54.

Authors:  C Verhagen; A C Breebaart; M S Suttorp-Schulten; R Hoekzema; M Van Haren; A Kijlstra
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

4.  Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.

Authors:  A Ishiko; H Shimizu; A Kikuchi; T Ebihara; T Hashimoto; T Nishikawa
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 5.  Management of autoimmune skin disorders in the elderly.

Authors:  Wei Jing Loo; Nigel P Burrows
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

6.  A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

Authors:  Z Liu; L A Diaz; J L Troy; A F Taylor; D J Emery; J A Fairley; G J Giudice
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

Review 7.  The pathophysiology of bullous pemphigoid.

Authors:  Michael Kasperkiewicz; Detlef Zillikens
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

8.  Lymphotoxin detected in the blister fluid of bullous pemphigoid patients.

Authors:  E W Jeffes; R S Yamamoto; A R Ahmed; G A Granger
Journal:  J Clin Immunol       Date:  1984-01       Impact factor: 8.317

9.  Suppressor-cell functions in bullous pemphigoid.

Authors:  A R Ahmed
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

10.  Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice.

Authors:  Mircea Teodor Chiriac; Emilia Licarete; Alexandra Gabriela Sas; Andreea Maria Rados; Iulia Lupan; Anca Mirela Chiriac; Hilda Speth; Vlad Pop-Vancia; Iacob Domsa; Alina Sesarman; Octavian Popescu; Cassian Sitaru
Journal:  Orphanet J Rare Dis       Date:  2013-01-29       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.